Funding for insurance businesses and insurtechs in South Africa
Which insurance business are you — and which capital do you need?
A licensed insurer raising regulatory capital faces solvency requirements and Prudential Authority scrutiny — that capital is priced and structured for permanence. A UMA needs no regulatory capital of its own but raises growth capital against its underwriting result and book persistency. An insurtech is a technology raise judged on distribution economics: cost per policy, lapse rates, loss ratios of the book it builds. Conflating these models in a pitch is the fastest way to lose a funder who knows the sector.
What the money looks for
Persistency and loss ratios above all — growth that lapses is expense, not value. For UMAs and cell-captive businesses: the durability of the carrier relationship. For insurtechs: whether distribution economics survive without the founder selling. South African funders in this space include specialist financial-services PE, corporate venture arms of the large insurers, and international fintech investors entering through the corridor.
Where Caban fits
Structuring the raise to match the model, preparing loss and persistency data to diligence standard, and — for founders whose endgame is a trade sale to a major insurer — running that process when the book is ready.
Questions, answered
How do insurtech startups get funded in South Africa?
As technology businesses judged on insurance metrics: cost of policy acquisition, persistency, and the loss ratio of the book they build. Venture capital, corporate venture arms of large insurers, and international fintech investors are the usual sources.
What is the difference between regulatory capital and growth capital in insurance?
Regulatory capital is what the Prudential Authority requires a licensed insurer to hold against the risk it underwrites — permanent, tightly structured. Growth capital funds distribution, technology and acquisitions, and is raised like any growth equity, judged on the book’s economics.
Can a UMA raise investment?
Yes — UMAs raise against underwriting results, persistency and the strength of the carrier relationship. Because they don’t hold regulatory capital, the raise is structurally simpler than for a licensed insurer, and trade sales to carriers are a common exit.